These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 18313769)

  • 1. Molecular strategies to inhibit the replication of RNA viruses.
    Leyssen P; De Clercq E; Neyts J
    Antiviral Res; 2008 Apr; 78(1):9-25. PubMed ID: 18313769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly pathogenic RNA viral infections: challenges for antiviral research.
    Bray M
    Antiviral Res; 2008 Apr; 78(1):1-8. PubMed ID: 18243346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral drugs for viruses other than human immunodeficiency virus.
    Razonable RR
    Mayo Clin Proc; 2011 Oct; 86(10):1009-26. PubMed ID: 21964179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses.
    McKimm-Breschkin JL; Fry AM
    Antiviral Res; 2016 May; 129():21-38. PubMed ID: 26872862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleosides for the treatment of respiratory RNA virus infections.
    Jordan PC; Stevens SK; Deval J
    Antivir Chem Chemother; 2018; 26():2040206618764483. PubMed ID: 29562753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Virus Capsid as a Tool to Fight RNA Viruses.
    Hozáková L; Vokatá B; Ruml T; Ulbrich P
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses.
    Tampere M; Pettke A; Salata C; Wallner O; Koolmeister T; Cazares-Körner A; Visnes T; Hesselman MC; Kunold E; Wiita E; Kalderén C; Lightowler M; Jemth AS; Lehtiö J; Rosenquist Å; Warpman-Berglund U; Helleday T; Mirazimi A; Jafari R; Puumalainen MR
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33322045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza virus neuraminidase inhibitors.
    Gubareva LV; Kaiser L; Hayden FG
    Lancet; 2000 Mar; 355(9206):827-35. PubMed ID: 10711940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies of development of antiviral agents directed against influenza virus replication.
    Hsieh HP; Hsu JT
    Curr Pharm Des; 2007; 13(34):3531-42. PubMed ID: 18220789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile 2008 (2nd edition): RNA viruses.
    De Clercq E; Field HJ
    Antivir Chem Chemother; 2008; 19(2):63-74. PubMed ID: 18727441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting viral genome synthesis as broad-spectrum approach against RNA virus infections.
    Huchting J
    Antivir Chem Chemother; 2020; 28():2040206620976786. PubMed ID: 33297724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway.
    Pattabhi S; Wilkins CR; Dong R; Knoll ML; Posakony J; Kaiser S; Mire CE; Wang ML; Ireton RC; Geisbert TW; Bedard KM; Iadonato SP; Loo YM; Gale M
    J Virol; 2015 Dec; 90(5):2372-87. PubMed ID: 26676770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon.
    Markland W; McQuaid TJ; Jain J; Kwong AD
    Antimicrob Agents Chemother; 2000 Apr; 44(4):859-66. PubMed ID: 10722482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Drug Targets of Single-Stranded RNA Viruses Causing Chronic Human Diseases.
    Dinesh DC; Tamilarasan S; Rajaram K; Bouřa E
    Curr Drug Targets; 2020; 21(2):105-124. PubMed ID: 31538891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of RNA virus infections with peptide-conjugated morpholino oligomers.
    Stein DA
    Curr Pharm Des; 2008; 14(25):2619-34. PubMed ID: 18991679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA virus error catastrophe: direct molecular test by using ribavirin.
    Crotty S; Cameron CE; Andino R
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6895-900. PubMed ID: 11371613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuraminidase inhibitors for treatment of influenza A and B infections.
    MMWR Recomm Rep; 1999 Dec; 48(RR-14):1-9. PubMed ID: 10632443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear trafficking of proteins from RNA viruses: potential target for antivirals?
    Caly L; Wagstaff KM; Jans DA
    Antiviral Res; 2012 Sep; 95(3):202-6. PubMed ID: 22750233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R430: A potent inhibitor of DNA and RNA viruses.
    D'Aiuto L; McNulty J; Hartline C; Demers M; Kalkeri R; Wood J; McClain L; Chattopadhyay A; Zhi Y; Naciri J; Smith A; Yolken R; Chowdari K; Zepeda-Velazquez C; Dokuburra CB; Marques E; Ptak R; Kinchington P; Watkins S; Prichard M; Bloom D; Nimgaonkar V
    Sci Rep; 2018 Nov; 8(1):16662. PubMed ID: 30413769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCX4430 - A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease.
    Taylor R; Kotian P; Warren T; Panchal R; Bavari S; Julander J; Dobo S; Rose A; El-Kattan Y; Taubenheim B; Babu Y; Sheridan WP
    J Infect Public Health; 2016; 9(3):220-6. PubMed ID: 27095300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.